Spike-in controls – what’s your take?
In staying up to date with the latest trends in industry, the folks at Cofactor, myself included, often take a look at some popular blogs and other sources of information. Recently while [...]
Notes on 23andMe and the FDA
While Cofactor is in the business of helping pharmaceutical, biofuel, and agricultural researchers discover more about the DNA & RNA they study, I wanted to take a moment to discuss an item [...]
Don’t Always Take the Limo
We frequently get asked by our clients how we'd approach looking at a sequencing quote. When you're looking at 2 (or 3, or 7, or 10) different next-gen quotes you'd think it'd [...]
